Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Clinical Genitourinary Cancer|April 15, 2026
Real-World Effectiveness and Treatment Persistence of Darolutamide, Apalutamide, and Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer: A Multicenter StudyShuhei Hara, Keiichiro Mori, Masaki Hashimoto, et al.
International Journal of Clinical Oncology|July 15, 2026
Real-world evaluation of primary prophylactic use of granulocyte colony-stimulating factor in patients with metastatic castration-sensitive prostate cancer treated with triplet therapyMasataka Kubo, Fumihiko Urabe, Kojiro Tashiro, et al.
Japanese Journal of Clinical Oncology|January 17, 2025
Evaluation of optimal timing and therapeutic efficacy of radium-223 therapy for metastatic castration-resistant prostate cancer: a multicenter collaborative studyFumihiko Urabe, Soshi Kadena, Kojiro Tashiro, et al.
World Journal of Urology|May 21, 2022
Combination of docetaxel versus nonsteroidal antiandrogen with androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer: a propensity score-matched analysisTakafumi Yanagisawa, Takahiro Kimura, Kenichi Hata, et al.
Japanese Journal of Clinical Oncology|October 19, 2024
Optimal timing for initiating androgen receptor signaling inhibitor therapy in patients with nonmetastatic castration-resistant prostate cancer: a multicenter collaborative studyShuhei Hara, Fumihiko Urabe, Kojiro Tashiro, et al.
International Journal of Clinical Oncology|December 9, 2025
Clinical profiles and predictors of symptomatic skeletal events in patients with metastatic castration-resistant prostate cancer receiving denosumabMana Nakata, Fumihiko Urabe, Yu Imai, et al.
BJUI Compass|August 7, 2025
Bilateral vas deferens suturing to prevent inguinal hernias after radical prostatectomyKenichi Hata, Yuma Goto, Masaki Hashimoto, et al.
Pageof 3